Market Movers: Top News & Stocks in Focus🌟
📰Top News
👉US Q2 GDP grows at 2.8% vs 2.0% estimated, on the back of strong consumer spending.
📊Stocks in Focus/Earnings Preview
👉Sun Pharma:
Co's LEQSELVI (DEURUXOLITINIB) receives US FDA approval, achieves significant efficacy in phase 3 trials.
👉HERO MOTOCO:
ITAT favours company, the entire tax demand of Rs. 2336.71Cr for assessment year 2011-12 has been quashed.
📰Top News
👉US Q2 GDP grows at 2.8% vs 2.0% estimated, on the back of strong consumer spending.
📊Stocks in Focus/Earnings Preview
👉Sun Pharma:
Co's LEQSELVI (DEURUXOLITINIB) receives US FDA approval, achieves significant efficacy in phase 3 trials.
👉HERO MOTOCO:
ITAT favours company, the entire tax demand of Rs. 2336.71Cr for assessment year 2011-12 has been quashed.